Results for untargeted MS search on m/z: (+/-) mode
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN000377 | MID42085:(6RS)-6,19-epidioxy-24,24-difluoro-25-hydroxy-6,19-dihydrovitamin D3 / (6RS)-6,19-epidioxy- | 0.75 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Amphibine B | 0.97 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Spectinomycin adenylate | 0.97 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | DG(17:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)[iso2] | 0.97 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Fraxin | 0.97 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Glucocerebrosides | 0.97 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PI(20:4(5Z,8Z,11Z,14Z)/0:0) | 0.98 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Glafenine | 0.99 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Parillin | 0.99 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PG(20:5(5Z,8Z,11Z,14Z,17Z)/0:0) | 1 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Orlistat | 1 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | D-Glucosyldihydrosphingosine | 1 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Methoprene (S) | 1 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Colnelenic acid | 1 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | 14-Deacetylnudicauline | 1.01 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Dicyclohexyl phthalate | 1.02 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Dinor-PGD2 | 1.02 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | IU1 | 1.03 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | methyl 10,12,13,15-bisepidioxy-16-hydroperoxy-8E-octadecenoate | 1.03 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | 5-O-Methylvisamminol | 1.04 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | MG(0:0/22:0/0:0) | 1.04 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Glucosylceramide (d18:1/18:0) | 1.06 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Tributyl phosphate | 1.06 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Septentriodine | 1.08 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | gypsogenin 3-O-rhamnosylglucosiduronic acid | 1.08 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | MID42395:26,27-diethyl-1?,25-dihydroxy-22-thiavitamin D3 / 26,27-diethyl-1?,25-dihydroxy-22-thiachol | 1.08 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Oleoyl-EA(d2) | 1.09 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Naloxone-3-glucuronide | 1.09 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | MID42333:24,24-difluoro-1?,25-dihydroxy-26,27-dimethylvitamin D3 / 24,24-difluoro-1?,25-dihydroxy-26 | 1.09 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Labriformidin | 1.09 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PS(18:3(6Z,9Z,12Z)/19:1(9Z)) | 1.1 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Lys Tyr Ile | 1.11 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Cyclopiazonic Acid | 1.11 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Gln Glu Lys | 1.11 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Tyr Val Phe | 1.11 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Linoleoyl Ethanolamide | 1.12 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Lucidine B | 1.12 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | 5-O-Methylembelin | 1.14 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Sativic acid | 1.14 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | LacCer(d18:0/26:0) | 1.15 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Harpagoside | 1.15 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Ferroxamine | 1.15 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Uscharidin | 1.15 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PS(O-16:0/13:0) | 1.16 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Gal?1-3Gal?1-4GlcNAc?-Sp | 1.17 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Glu Met Trp | 1.17 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Azatadine | 1.17 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Hydroxytetrabenazine glucuronide | 1.17 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | 3-Indolebutyric acid | 1.18 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | N-methylundec-10-enamide | 1.18 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Oxolucidine B | 1.19 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | MID42466:11?-(4-dimethylaminophenyl)-1?,25-dihydroxyvitamin D3 / 11?-(4-dimethylaminophenyl)-1?,25-d | 1.19 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | 1'H-5alpha-Cholest-2-eno[3,2-b]indole | 1.2 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Aridanin | 1.2 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | N-acyl capnines | 1.2 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | N-acyl capnines | 1.21 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Pseudopelletierine | 1.22 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Ethanolamine | 1.26 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Spheroidene | 1.26 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | 20,21,21-Trifluoro-3-methoxy-19-nor-17alpha-pregna-1,3,5(10),20-tetraen-17-ol | 1.26 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Boschniakine | 1.27 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Lys Val Lys | 1.29 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Bz-Arg-OEt | 1.31 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PE(17:2(9Z,12Z)/20:0) | 1.31 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PS(O-16:0/12:0) | 1.34 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PS(O-16:0/12:0) | 1.36 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | ICI 164384 | 1.37 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Gly Lys Phe | 1.38 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | CerP(d18:1/20:0) | 1.39 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Sphingofungin D | 1.43 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PE(17:2(9Z,12Z)/20:0) | 1.44 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Istamycin C | 1.45 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | CerP(d18:1/18:0) | 1.46 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Amoxicillin | 1.47 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Peucenin | 1.48 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Sannamycin A | 1.51 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | CerP(d18:1/20:0) | 1.52 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Lithocholic acid taurine conjugate | 1.54 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PS(P-16:0/22:1(11Z)) | 1.54 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | 1-(alpha-Methyl-4-(2-methylpropyl)benzeneacetate)-beta-D-Glucopyranuronic acid | 1.55 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PE(P-18:1(11Z)/15:0) | 1.57 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Cys Cys Ile | 1.58 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Niacinamide | 1.6 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PE(P-16:0/19:0) | 1.65 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Hexazinone | 1.67 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PE(O-16:0/17:0) | 1.68 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PS(20:0/20:1(11Z)) | 1.73 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PE(17:1(9Z)/18:0) | 1.78 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PE-NMe(18:0/18:0)[U] | 1.85 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | 5?-Deoxy-5?-(methylthio)adenosine | 1.98 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PS(O-16:0/20:1(11Z)) | 2 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PS(O-16:0/22:0) | 2.07 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Butyric acid | 2.15 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Pirimicarb | 2.15 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Paraldehyde | 2.16 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Deoxyadenosine | 2.23 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Ergine | 2.32 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PS(22:0/20:2(11Z,14Z)) | 2.34 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PE(14:0/22:2(13Z,16Z)) | 2.35 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Khellin | 2.41 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Nitrothal-isopropyl | 2.43 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Nap-Trp-OH | 2.47 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Lys Cys Asn | 2.61 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Hypoxanthine | 2.62 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Lys Ser Lys | 2.74 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PS(P-20:0/17:1(9Z)) | 2.74 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Neobanone | 2.76 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Guanine | 2.77 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Phosphatidyl glycerol | 2.77 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Tyr Thr Lys | 2.81 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Myricetin 3-glucuronide | 2.86 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Neu5Ac?2-6GalNAc?-Thr | 2.87 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | N,N-Dimethyltryptamine (DMT) | 2.89 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | ?-Methyltryptamine (AMT) | 2.89 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Fenbuconazole | 2.97 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Leu Cys Phe | 2.97 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Fortimicin A | 3.05 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Ins-1-P-Cer(t18:0/26:0) | 3.06 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Neopinone | 3.15 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | acetohydroxamic acid | 3.17 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Phenylacetylglycine | 3.17 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | sn-glycero-3-Phosphoethanolamine | 3.17 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Bispyribac | 3.17 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Serotonin | 3.37 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Patuletin 3-(6''-(E)-feruloylglucoside) | 3.38 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Enterochelin | 3.38 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Ornaline | 3.39 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | N4-Acetylsulfadoxine | 3.42 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Adenine | 3.44 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Erythrono-1,4-lactone | 3.44 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PS(15:1(9Z)/14:1(9Z)) | 3.47 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | N-Formylmethionylphenylalanine | 3.56 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Compound III(S) | 3.59 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Citiolone | 3.69 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | JWH 018 4-hydroxyindole metabolite | 3.69 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Nizatidine | 3.79 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | N-(2-hydroxyethyl)henicosanamide | 3.89 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Cytarabine | 3.89 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Haplanthin | 3.89 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | n-Pentadecylamine | 3.9 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Istamycin C1 | 3.93 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Trp-Lys-OH | 3.97 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Cytosine | 3.97 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Deoxycytidine | 3.98 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Creatinine | 4 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Netilmicin | 4.26 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Patuletin 3-(6''-(E)-feruloylglucoside) | 4.3 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Elloramycin A | 4.31 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Tyrphostin B44 (-) | 4.31 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Orizabin | 4.31 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | ?-Caprolactam | 4.31 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Trichotomine | 4.35 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | FKGK 11 | 4.77 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Isobutyronitrile | 4.9 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PS(O-18:0/12:0) | 4.9 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | (-)-Hygroline | 4.91 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Malyngamide J | 4.97 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PI(19:1(9Z)/0:0) | 4.98 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Isoalangiside | 5.01 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Chivosazole F | 5.01 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PS(18:1(9Z)/16:1(9Z)) | 5.04 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | 11-amino-undecanoic acid | 5.06 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Digitoxigenin bisdigitoxoside | 5.14 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PS(12:0/14:0) | 5.14 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Symlandine | 5.35 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Erythromycin B | 5.45 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Yamogenin 3-O-neohesperidoside | 5.47 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Gymnemic acid I | 5.49 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | 5-Acetylamino-6-formylamino-3-methyluracil | 5.52 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | NS 1619 | 5.52 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Daunorubicin | 5.54 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Streptomycin | 5.72 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Pratensin A | 5.75 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Jadomycin B | 5.76 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Lankacidin C | 5.77 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Rescinnamine | 5.77 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Pencycuron | 5.77 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | L-Isoleucine | 5.77 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Piperidine | 5.77 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Trimethylamine | 5.79 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Tyrphostin B44 (-) | 5.81 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Pratensin A | 5.81 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | His-Thr-OH | 5.84 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Phaseolotoxin | 5.84 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Phenylpyruvic acid | 5.85 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Guanidinosuccinic Acid | 5.85 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | L-Leucine | 5.85 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Isoprene | 5.85 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | 5-O-(Indol-3-ylacetyl-myo-inositol) D-galactoside | 5.86 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | THTC | 5.86 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Oxotolrestat glucuronide | 5.86 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Coumarin | 5.86 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Diglycolic acid | 5.86 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Caylin-2 | 5.87 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Medermycin | 5.88 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | E3040 glucuronide | 5.88 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Chlorophyllide b | 5.88 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Penicilloic G acid | 5.92 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/19:0) | 5.94 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Tyr Asp His | 5.99 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | 3-(7'-Methylthio)heptylmalic acid | 5.99 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Rifamycin S | 5.99 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Ingenol 3,20-dibenzoate | 6 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Pyrromycin | 6 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Tyr Glu Glu | 6 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Chlorophyll a | 6.14 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | PS(20:1(11Z)/0:0) | 6.3 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | N-(3-pyridyl)-Indomethacin amide | 6.34 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | 5-Amino-1-ribofuranosylimidazole-4-carboxyamide | 6.35 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | dIMP | 6.35 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Gln Asn Glu | 6.35 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Sulfamerazine | 6.38 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | cefoperazone | 6.39 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Kinetin Riboside | 6.55 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Phe4Cl-His-OH | 6.55 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Prothioconazole | 6.55 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Luteolin 7,3'-digalacturonide | 6.55 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | alpha,beta-Dihydroxyethyl-TPP | 6.55 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Leoidin Dimethyl Ether | 6.56 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Tricetin 3'-methyl ether 7,5'-diglucuronide | 6.56 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | UDP-N-acetylmuraminate | 6.56 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Quercetin 3-(6''-malonylglucoside)-7-glucoside | 6.58 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Penicillin G | 6.58 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | 5-Aminopentanoic acid | 6.64 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Firocoxib | 6.77 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Clindamycin phosphate | 6.78 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Phenylbutyrylglutamine | 6.79 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Helilandin B | 6.79 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | 5-Nitro-ortho-anisidine | 6.79 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | 6-Imino-5-oxocyclohexa-1,3-dienecarboxylate | 6.79 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Homoserine lactone | 6.79 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Pyrroline hydroxycarboxylic acid | 6.8 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Met-Trp-OH | 6.82 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Creatine | 7 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Sarcosine | 7.01 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Queuine | 7.05 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Disulfiram | 7.25 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | 4-Methylene-L-glutamine | 7.33 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | D-Proline | 7.39 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Phosphinothricin | 7.43 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Met Arg | 7.43 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Streptidine | 8.24 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | V-PYRRO/NO | 8.28 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Prorepensin | 8.29 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | 3-Buten-1-amine | 8.3 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Dehydrofalcarinone | 8.44 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Ouabain | 8.5 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | Digoxigenin bisdigitoxoside | 8.52 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | p-Hydroxypropoxyphene | 8.56 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000377 | ADMA | 8.57 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages |
